By inhibiting DPP-4, one can enhance the half-life of GLP-1 and GIP already existing in the body
Consequently, 400600 peptides are currently being reviewed for the treatment of various ailments, including cancer (4)
Selank and Semax Neuropeptides studied for anxiolytic effects, cognitive function, BDNF enhancement, and stress resilience
- 180 sprays, each spray is 25MCG of Ipamorelin and CJC No DAC Oral Spray
Please note that we do not provide Semaglutide GLP-1 treatment for individuals with a history of cancer, diabetes, during pregnancy or breastfeeding, or for those with a family history of thyroid cancer and pancreatitis
The increasing prevalence of type 2 diabetes and obesity in Europe is increasing the demand for GLP-1 drugs